Published in Biochim Biophys Acta on May 27, 1997
Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer (1999) 1.38
A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis. Oncogene (2009) 1.35
Angiogenesis in melanoma. Semin Oncol (2007) 1.30
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer (1999) 1.24
TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells. Cancer Res (2012) 1.20
Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations. Am J Pathol (2001) 1.07
Methionine sulfoxide reductase A down-regulation in human breast cancer cells results in a more aggressive phenotype. Proc Natl Acad Sci U S A (2010) 1.00
Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1. Mol Cancer Res (2011) 0.98
Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression. Exp Mol Med (2012) 0.98
Angiogenesis and progression in human melanoma. Dermatol Res Pract (2010) 0.88
Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter. Am J Pathol (2001) 0.86
Pump-probe imaging of pigmented cutaneous melanoma primary lesions gives insight into metastatic potential. Biomed Opt Express (2015) 0.86
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol (2001) 1.87
Complications of cancer immunotherapy with levamisole. Lancet (1977) 1.76
Metabolic effects of controlled jejunocolic bypass. Arch Surg (1967) 1.35
Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology (1996) 1.32
Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res (1994) 1.30
Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin. J Clin Invest (1992) 1.26
Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res (1999) 1.16
Randomized trial of 3-hour versus 24-hour infusion of high-dose paclitaxel in patients with metastatic or locally advanced breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26. J Clin Oncol (1999) 1.07
The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis. Horm Metab Res (2004) 1.05
Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer (1993) 1.04
Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities. Cancer Res (1986) 1.03
Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor. J Immunol (1978) 1.03
Combined surgery and cryotherapy for diffuse malignant melanoma of the conjunctiva. Arch Ophthalmol (1980) 1.02
Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res (1995) 1.00
Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Exp Cell Res (1998) 0.99
Structure-activity studies of the thrombin receptor activating peptide. Biochem Biophys Res Commun (1992) 0.97
Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy. Biochem Pharmacol (2000) 0.95
Carcinoma of the pancreas and periampullary region: a 41 year experience. Ann Surg (1977) 0.95
Peutz-Jeghers syndrome with jejunal and colonic adenocarcinomas. Can Med Assoc J (1970) 0.95
Influence of prolonged epidural blockade on blood sugar and cortisol responses to operations upon the upper part of the abdomen and the thorax. Surg Gynecol Obstet (1971) 0.94
Integrin alpha3beta1 can promote adhesion and spreading of metastatic breast carcinoma cells on the lymph node stroma. Int J Cancer (1996) 0.93
Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer. Oncogene (2012) 0.93
Studies on clonal heterogeneity in two spontaneously metastasizing mammary carcinomas of recent origin. Int J Cancer (1985) 0.93
Absence of a pilus receptor for filamentous phage IKe. Nature (1974) 0.91
Hyperbaric oxygen: a review of treatment in eighty-three patients. Can Med Assoc J (1967) 0.89
The role of the integrin vitronectin receptor, alpha v beta 3 in melanoma metastasis. Cancer Metastasis Rev (1995) 0.89
Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene (2011) 0.89
Reduction of tumorigenicity by alpha 3 integrin in a rhabdomyosarcoma cell line. Cell Adhes Commun (1996) 0.89
The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis. Surg Oncol Clin N Am (2001) 0.88
Alterations in body composition following intestinal bypass for morbid obesity. Surgery (1976) 0.87
Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. J Clin Invest (1995) 0.87
Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3. Int J Cancer (2001) 0.86
Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense. Hum Gene Ther (2001) 0.85
Natural resistance mechanisms may play a role in protection against chemical carcinogenesis. Cancer Immunol Immunother (1982) 0.85
Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor. Cancer Res (1998) 0.85
Gastrointestinal complications after radiotherapy for carcinoma of the uterine cervix. Can J Surg (1982) 0.85
Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length. Int J Cancer (1998) 0.84
Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions. J Biol Chem (2001) 0.84
Increased natural host resistance mechanisms in B lymphocyte-deprived mice. J Reticuloendothel Soc (1981) 0.84
Axillary lymphography in carcinoma of the breast. Surgery (1966) 0.82
Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64. Clin Exp Metastasis (1997) 0.82
Bedside diagnosis of massive pulmonary embolism. Arch Surg (1966) 0.82
Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels. Oncogene (2008) 0.82
Pulmonary embolism: the value of bedside scanning, angiography and pulmonary embolectomy. Can Med Assoc J (1967) 0.81
Eradication of hepatic metastases of carcinoma H-59 by combination chemoimmunotherapy with liposomal muramyl tripeptide, 5-fluorouracil, and leucovorin. Cancer Res (1992) 0.81
Primary malignant tumors of the small intestine. Dis Colon Rectum (1979) 0.81
Isolation and characterization of rat lymphatic endothelial cells. Microcirc Endothelium Lymphatics (1991) 0.81
Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res (1992) 0.80
The loss of E-cadherin mRNA transcripts in rat prostatic tumors is accompanied by increased expression of mRNA transcripts encoding fibronectin and its receptor. Clin Exp Metastasis (1994) 0.80
An analysis of host T-cell subsets based on Lyt antigenic markers during the development of spontaneous C3H mammary carcinomas. Cell Immunol (1984) 0.79
Small-bowel resection for metastatic melanoma. Can J Surg (1996) 0.79
Sustained production of a soluble IGF-I receptor by gutless adenovirus-transduced host cells protects from tumor growth in the liver. Cancer Gene Ther (2013) 0.79
Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol (1988) 0.79
Lewis lung carcinoma variants with differing metastatic specificities adhere preferentially to different defined extracellular matrix molecules. Invasion Metastasis (1988) 0.78
HIV-1 associated Kaposi's sarcoma in an African population. Can J Oncol (1994) 0.78
Identification of an Mr 64,000 plasma membrane glycoprotein mediating adhesion of tumor H-59 cells to hepatocytes. Cancer Res (1991) 0.77
Immunotherapy of human malignant melanoma with irradiated tumor cells, oral Bacillus Calmette-Guérin, and levamisole. Ann N Y Acad Sci (1976) 0.77
Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res (1994) 0.77
Morphologic changes of the liver following small intestinal bypass for obesity. Arch Surg (1971) 0.77
Antitumor immunity in B-lymphocyte-deprived mice. II. In vitro studies. Cell Immunol (1981) 0.77
A monoclonal antibody to Lewis lung carcinoma variant H-59 identifies a plasma membrane protein with apparent relevance to lymph node adhesion and metastasis. Cancer Res (1990) 0.76
Identification and importance of lymphocyte subpopulations in the regional lymph nodes of breast cancer patients. Can J Surg (1989) 0.76
The use of cryosurgery in the control of locally recurrent tumours. Can Med Assoc J (1970) 0.75
The present status of bypass operations for obesity. Surg Annu (1977) 0.75
Lectin binding by liver and lung metastasizing variants of the murine Lewis lung carcinoma. Am J Pathol (1988) 0.75
Productivity of needle localization to facilitate excision of nonpalpable, mammographically suspicious lesions. Can J Surg (1991) 0.75
Inhibition of experimental hepatic metastasis by a monoclonal antibody that blocks tumor-hepatocyte interaction. J Immunother Emphasis Tumor Immunol (1994) 0.75
Cross-implantation of tumor tissue and cross-transfusion in patients with advanced cancer. Am J Obstet Gynecol (1970) 0.75
Cutaneous melanoma: "is it as black as it seems"? J Dermatol (1986) 0.75
Lymphoscintigraphy in the staging of breast cancer. Can J Surg (1983) 0.75
Blood gas and neurological responses to inhalation of oxygen at 3 atmospheres. Proc Soc Exp Biol Med (1966) 0.75
Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study. Cancer Treat Rep (1987) 0.75
Changes in the host lymphocyte subsets during chemical carcinogenesis. Cancer Res (1983) 0.75
Differences in the metastatic potential of two sublines of tumor 3LL selected for resistance to natural NK-like effector cells. Cancer Immunol Immunother (1983) 0.75
Differences in immunogenicity between the local tumor 3LL and its metastasis-derived line as detected by sensitization with antigen-fed macrophages. Invasion Metastasis (1982) 0.75
Tumor immunology--three decades in review. Annu Rev Microbiol (1983) 0.75
Development of critical appraisal skills in medical students: opportunities in oncology-related learning situations. J Cancer Educ (1991) 0.75
Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor. Biochem Biophys Res Commun (1998) 0.75
Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus. Arch Virol (1990) 0.75
Double blind randomized prospective trial of levamisole/placebo in stage I cutaneous malignant melanoma. Clin Invest Med (1987) 0.75
Metabolic effects of controlled jejunocolic bypass. Surg Forum (1966) 0.75
Clinical evaluation of liposomal tumor antigen vaccines in patients with stage-III melanoma. Cancer Detect Prev (1990) 0.75
Correction of regional ventilation-perfusion imbalance in obesity by weight reduction caused by intestinal bypass. Surg Forum (1968) 0.75
Alterations of hepatic triglyceride in patients before and after jejunoileal bypass for morbid obesity. Gastroenterology (1979) 0.75